NCT06705790

Brief Summary

The goal of this trial is to learn about the feasibility and benefits of delivering a pelvic floor muscle training program to people with motor-incomplete spinal cord injury. The main questions it aims to answer are:

  1. 1.To evaluate the feasibility of delivering a pelvic floor muscle training program to people with spinal cord injury. The investigators will examine recruitment rate, compliance and adherence to the intervention and other study protocols, adverse events, and participant perspectives of the study protocols.
  2. 2.To explore the potential effectiveness of pelvic floor muscle training on pelvic floor, bladder, bowel, and sexual function.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Mar 2025Mar 2027

First Submitted

Initial submission to the registry

November 18, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 26, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

March 7, 2025

Status Verified

March 1, 2025

Enrollment Period

2.1 years

First QC Date

November 18, 2024

Last Update Submit

March 4, 2025

Conditions

Keywords

Spinal Cord InjuryPelvic Floor Muscle TrainingBladderBowelSexual Health

Outcome Measures

Primary Outcomes (4)

  • Feasibility - Recruitment Rate

    Recruitment rate will be evaluated by number of participants approached, screened for eligibility, as well as reasons for exclusions.

    Through study completion, up to 12 weeks

  • Feasibility - Compliance

    Compliance will be tracked by the adherence of participants to the prescribed exercise program, with reasons for missed sessions or drop-outs noted.

    Through study completion, up to 12 weeks

  • Feasibility - Adverse Events

    Any adverse events to study protocols will be recorded.

    Through study completion, up to 12 weeks

  • Feasibility - Acceptability

    The acceptability of the intervention will be evaluated using a 7-point Likert scale to rate participants' enjoyment of the exercise program and whether they felt the program was beneficial for improving their bladder, bowel, and/or sexual function.

    Through study completion, up to 12 weeks

Secondary Outcomes (13)

  • Incontinence Quality of Life Questionnaire (I-QoL)

    From enrollment to within 2 weeks of completing the study intervention

  • Neurogenic Bladder Symptoms Score (NBSS)

    From enrollment to within 2 weeks of completing the study intervention

  • 3-Day Bladder Diary

    From enrollment to within 2 weeks of completing the study intervention

  • Timed Bowel Movement

    From enrollment to within 2 weeks of completing the study intervention

  • Neurogenic Bowel Dysfunction Score (NBDS)

    From enrollment to within 2 weeks of completing the study intervention

  • +8 more secondary outcomes

Study Arms (1)

Pelvic Floor Muscle Training Group

EXPERIMENTAL
Behavioral: Pelvic Floor Muscle Training

Interventions

Pelvic floor muscle training 5x/week for 12-weeks

Pelvic Floor Muscle Training Group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are at least 19 years of age.
  • Have a non-progressive, motor-incomplete spinal cord injury that is at or above the T12 neurological level at least 12 months ago.
  • Have symptoms of bladder, bowel, and/or sexual dysfunction that are caused by your spinal cord injury.
  • Have stable management of spinal cord related secondary health concerns (e.g., spasticity, neuropathic pain).
  • Are able to speak and understand English.

You may not qualify if:

  • Are currently pregnant, have been pregnant within the past 6 months, or are planning to become pregnant in the next 6 months.
  • Have had urogenital surgery within the past 12 months.
  • Have received Botox bladder injections within the past 4 weeks, or anticipate receiving an injection in the next 6 months.
  • Have presence of severe medical issue that in the investigator's judgement would adversely affect the participant's participation in the study. Examples include, but are not limited to pressure sores, cardiovascular disease, and unmanaged diabetes.
  • Have any permanent metal fixtures in their head (excluding dental fillings), or pacemakers, stimulators, or implanted medication pumps.
  • Have a history of seizures, are taking medications that lower the seizure threshold, or experience recurring headaches.
  • Have a condition for which exercise is contraindicated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blusson Spinal Cord Centre

Vancouver, British Columbia, V5Z1M9, Canada

RECRUITING

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Tania Lam, PhD, PT

    University of British Columbia, ICORD

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 18, 2024

First Posted

November 26, 2024

Study Start

March 1, 2025

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

March 7, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations